Major histocompatibility complex class II–PAP peptide–T cell receptor complex

The major histocompatibility complex class II–PAP peptide–T cell receptor complex is a ternary molecular assembly central to adaptive immunity. MHC class II molecules, expressed on antigen-presenting cells, present peptides (such as those derived from prostatic acid phosphatase) to specific CD4+ T cell receptors, triggering T cell activation. Structural studies have shown that TCRs engage both the presented peptide and the MHC class II molecule, with specificity determined by the composition of the peptide and the precise interaction geometry between the three components[2][3][6]. Recognition of peptide–MHC class II complexes by TCRs underlies immune surveillance, tolerance, and the pathogenesis of autoimmunity and cancer[3][5][6]. The "MHC class II:PAP-peptide:TCR complex" is a conceptual entity in immunological and structural studies rather than a canonical single-protein drug target.

Other names

MHC-II:peptide:TCR complexpMHC-II:TCR complexpeptide–MHC class II:TCR complex

Modulation of TCR signaling (checkpoint inhibitors, TCR-based therapies); Immune activation or suppression through engagement/blockade of MHC–TCR interactions.